We're making nearly 300% gains on a rising pharmaceutical stock
Shortly after the opening bell, we will sell 10 shares of Eli Lilly at approximately $958 each. Following Monday's trade,…
Shortly after the opening bell, we will sell 10 shares of Eli Lilly at approximately $958 each. Following Monday's trade,…
Mother Sita Devi Yogendra, while running a separate section for women at the Yoga Institute when yoga was still predominantly…
The lucrative market for weight-loss drugs won’t be a duopoly forever. With billions at stake, that’s been a virtual guarantee…
Mandisa, the Grammy-winning Christian music singer and former “American Idol” contestant, died in April from complications of class III obesity,…
An injectable pen of Zepbound, Eli Lilly's weight loss drug, is on display in New York City on December 11,…
An April 24 letter from Vermont Sen. Bernie Sanders to Novo Nordisk's CEO began with a heartfelt thank you to…
Eli Lilly's weight-loss drug Zepbound showed promise as a treatment for sleep apnea, giving investors more confidence to continue owning…
The American Heart Association. He calls them “game changers.” Oprah Winfrey says they are “a gift.” Science magazine named them…
Sima Sistani, CEO, WW International, August 16, 2023. Scott Mlyn | CNBC WeightWatchers CEO Sima Sistani sent an internal memo…
There may be more reasons to invest in individual stocks than exchange-traded funds in the weight loss space. Amplify ETF…